Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.54% |
| 2 | Technology | 3.36% |
| 3 | Financials | 2.95% |
| 4 | Consumer Discretionary | 2.92% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCPC
2301
Balchem Corp
BCPC
$5.69B
| $8.3M | ﹤0.01% |
87,455
+68,326
| +357% | +$6.39M |
|
|
SJI
2302
DELISTED
South Jersey Industries, Inc.
SJI
| $8.28M | ﹤0.01% |
331,295
+270,333
| +443% | +$7.13M |
|
2303
PUT
ProShares Ultra S&P500
SSO
$8.47B
| $8.26M | ﹤0.01% |
528,000
-165,600
| -24% | -$2.34M |
|
2304
PUT
Nutrien
NTR
$32.6B
| $8.24M | ﹤0.01% |
256,700
+110,600
| +76% | +$3.85M |
|
|
NVO
2305
PUT
Novo Nordisk
NVO
$201B
| $8.23M | ﹤0.01% |
251,400
+87,600
| +53% | +$2.8M |
|
2306
Travel + Leisure Co
TNL
$4.63B
| $8.22M | ﹤0.01% |
291,859
+233,143
| +397% | +$6.31M |
|
2307
Assured Guaranty
AGO
$3.38B
| $8.22M | ﹤0.01% |
336,769
+228,744
| +212% | +$6.24M |
|
|
HBI
2308
DELISTED
Hanesbrands
HBI
| $8.22M | ﹤0.01% |
727,946
-406,038
| -36% | -$4.06M |
|
2309
PUT
Suncor Energy
SU
$77B
| $8.21M | ﹤0.01% |
487,200
+180,600
| +59% | +$3.09M |
|
2310
CALL
NovoCure
NVCR
$1.97B
| $8.17M | ﹤0.01% |
137,800
+300
| +0.2% | +$19.7K |
|
|
TWOU
2311
DELISTED
2U Inc
TWOU
| $8.17M | ﹤0.01% |
7,171
-237
| -3% | -$212K |
|
2312
Healthcare Services Group
HCSG
$1.48B
| $8.15M | ﹤0.01% |
333,360
+201,155
| +152% | +$4.76M |
|
|
JWN
2313
CALL
DELISTED
Nordstrom
JWN
| $8.15M | ﹤0.01% |
526,400
+74,200
| +16% | +$1.31M |
|
2314
EOG Resources
EOG
$74.8B
| $8.15M | ﹤0.01% |
160,942
-2,536,881
| -94% | -$123M |
|
2315
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
| $8.14M | ﹤0.01% |
359,232
-191,279
| -35% | -$4.09M |
|
2316
Texas Roadhouse
TXRH
$13.6B
| $8.13M | ﹤0.01% |
154,713
-300,557
| -66% | -$14.7M |
|
2317
Synchrony
SYF
$26.4B
| $8.13M | ﹤0.01% |
366,929
+200,696
| +121% | +$3.91M |
|
|
OYST
2318
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $8.13M | ﹤0.01% |
281,542
+261,668
| +1,317% | +$7.89M |
|
2319
Kinder Morgan
KMI
$73.1B
| $8.12M | ﹤0.01% |
535,445
-3,200,445
| -86% | -$48.6M |
|
|
ORTX
2320
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $8.12M | ﹤0.01% |
135,311
+48,806
| +56% | +$4.47M |
|
2321
CALL
Tyler Technologies
TYL
$13.5B
| $8.12M | ﹤0.01% |
23,400
+15,000
| +179% | +$5.03M |
|
2322
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $8.12M | ﹤0.01% |
+341,180
| New | +$7.63M |
|
2323
Lennar Class A
LEN
$20.9B
| $8.12M | ﹤0.01% |
+136,039
| New | +$6.95M |
|
2324
Gildan
GIL
$10.5B
| $8.11M | ﹤0.01% |
523,796
-437,606
| -46% | -$6.46M |
|
2325
PUT
Global Payments
GPN
$24.6B
| $8.11M | ﹤0.01% |
47,800
-13,200
| -22% | -$2.2M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 4.1% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.